1-20 of 35
Michal Bar-Natan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Opening Pandora's Box: Ultra-Deep Duplex Sequencing in Long Survivors with Acute Myeloid Leukemia

Gail J. Roboz, Nuria Mencia-Trinchant, Gabriela Pereira, Ellen K. Ritchie, Justin D. Kaner, Michael Samuel, Michal Bar-Natan, Jonathan Canaani, Sharmaine Griffith-Baker, Pinkal Desai, Monica L Guzman
Journal: Blood
Blood (2024) 144 (Supplement 1): 1576.
https://doi.org/10.1182/blood-2024-212090
Published: 2024
Journal Articles

Relative Influence of Socioeconomic and Biological Determinants of Outcomes in Adult Acute Lymphoblastic Leukemia

Juana Martinez, Michelle Becker, Megan Metzger, Nagma Shah, Erin Garbes Feliciano, Alberto Busmail Haylock, Navin Bhatt, Nikolaos Spyrou, John O. Mascarenhas, Douglas Tremblay, Jonathan Feld, Marina Kremyanskaya, Michal Bar-Natan, Hannah Levavi
Journal: Blood
Blood (2024) 144 (Supplement 1): 2798.
https://doi.org/10.1182/blood-2024-212243
Published: 2024
Journal Articles

Derivation and External Validation of a Venous Thromboembolism Risk Prediction Model in Patients with Acute Lymphoblastic Leukemia Receiving Asparaginase Therapy

Daniela R Anderson, Radhika Gangaraju, Wafik Sedhom, Eva N. Hamulyák, Tzu-Fei Wang, Kristen M. O'Dwyer, Brian J. Carney, Chandrasekar Muthiah, Michaela Liedtke, Talha Badar, Shai O. Shimony, Renana Robinson, Kristen M. Sanfilippo, Andriy Derkach, Shira N. Dinner, Bart J. Biemond, Kimberly H Seymour, David Nemirovsky, Leah A Goldberg, Anjani D Kapadia, Hannah Levavi, Michal Bar-Natan, Grace Van Hyfte, Karan Bansal, Marc Carrier, Jill Fulcher, Anke M Gerrits, Selina Luger, Guru Subramanian Guru Murthy, Marlise R. Luskin, Ofir Wolach, William Shomali, Jeffrey I. Zwicker, Wendy Stock, Avi Leader
Journal: Blood
Blood (2024) 144 (Supplement 1): 1250.
https://doi.org/10.1182/blood-2024-201997
Published: 2024
Journal Articles

A Polish Adult Leukemia Group (PALG) Prospective International Randomized Multicenter Clinical Trial to Compare the Efficacy of Two Standard Induction Therapies (DA-90 vs DAC) in Acute Myeloid Leukemia (AML) Patients ≤ 60 Years Old (PALG-AML1/2016) - Topline Results

Agnieszka Wierzbowska, Agnieszka Pluta, Anna Czyz, Marta Libura, Sebastian Giebel, Michał Soin, Damian Mikulski, Kacper Kościelny, Wojciech Fendler, Magdalena Czemerska, Agata Majchrzak, Anna Kopinska, Krzysztof Woźniczka, Martyna Włodarczyk, Karol Wójcik, Grzegorz Helbig, Małgorzata Raźny, Marta Sobas, Tomasz Wróbel, Donata Szymczak, Andrzej Szczepaniak, Lidia Gil, Magdalena Dutka, Maria Bieniaszewska, Tomasz Gromek, Marek Hus, Edyta Cichocka, Janusz Hałka, Elzbieta Patkowska, Marzena Wątek, Jolanta Wozniak, Ewa Lech-Maranda, Agata Obara, Agnieszka Kopacz, Katarzyna Dulik, Grzegorz Charlinski, Jerzy Holowiecki, Andi Rustani, Ameenah Sukkur, Nuria Mencia-Trinchant, Pinkal Desai, Michael Samuel, Justin D. Kaner, Michal Bar-Natan, Jonathan Canaani, Ellen K. Ritchie, Monica L Guzman, Sylvie D Freeman, Gail J. Roboz
Journal: Blood
Blood (2024) 144 (Supplement 1): 970.
https://doi.org/10.1182/blood-2024-202365
Published: 2024
Journal Articles

Enhancing Diagnostic and Prognostic Strategies in Secondary HLH: Insights from the Weill-Cornell Medicine Experience

Justin D. Kaner, Danny Luan, Franco Castillo Tokumori, John-William Sidhom, Jose Fernandez-Rengifo, Samantha Gerson, Matthew Whitcomb, Molly Vallon, Ellen K. Ritchie, Michael Samuel, Jonathan Canaani, Michal Bar-Natan, Erin Mulvey, Peter Martin, Pinkal Desai, John N. Allan, Richard R. Furman, Sarah C. Rutherford, Jia Ruan, Gail J. Roboz
Journal: Blood
Blood (2024) 144 (Supplement 1): 5379.
https://doi.org/10.1182/blood-2024-210134
Published: 2024
Journal Articles

Acute Leukemias of Ambiguous Lineage Have Durable Response to Hypomethylating Agents Plus Venetoclax in Older Patients

Joshua A Fein, Sanjay Patel, Neela Easwar, Michal Bar-Natan, Amy Chadburn, Pinkal Desai, Julia Geyer, Michael Kluk, Madhu M Ouseph, Ellen K. Ritchie, Michael Samuel, Paul Simonson, Gail J. Roboz, Justin D. Kaner
Journal: Blood
Blood (2023) 142 (Supplement 1): 1531.
https://doi.org/10.1182/blood-2023-190532
Published: 2023
Journal Articles

Molecular and Cytogenetic Characteristics of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) in Patients Exposed to Chemotherapy (CT) and/or Radiation (XRT)

Pinkal Desai, Yasmin Abaza, Hetty E. Carraway, Jason Chua, Michael Samuel, Cynthia Crispino, Bridget Foley, Sindhusha Veeraballi, Peter Doukas, Oluwatobi Odetola, Justin D. Kaner, Michal Bar-Natan, Ellen K. Ritchie, Gail J. Roboz
Journal: Blood
Blood (2023) 142 (Supplement 1): 821.
https://doi.org/10.1182/blood-2023-190478
Published: 2023
Journal Articles

Array CGH + SNP in ALL Enhances Detection of Complex Cytogenetic Profiles and Suggests That PRSS1 Loss May Play a Role in Leukemogenesis

Hannah Levavi, Daiva Ahire, Yosef Joseph Rene Amel Riazat-Kesh, Tianxiang Sheng, Dahniel L Sastow, Jonathan Feld, Douglas Tremblay, Marina Kremyanskaya, John Mascarenhas, Vesna Najfeld, Michal Bar-Natan
Journal: Blood
Blood (2023) 142 (Supplement 1): 6062.
https://doi.org/10.1182/blood-2023-185332
Published: 2023
Journal Articles

Prognostic Impact of Day 14 Bone Marrow (D14 BM Bx) in Acute Myeloid Leukemia (AML) in the Setting of European Leukemianet (ELN) Risk Classification

Metodi Balev, Nicole Zubizarreta, Erin Bresnahan, Jonathan Feld, Marina Kremyanskaya, Alla Keyzner, Alan H. Shih, Bridget K Marcellino, Lewis R. Silverman, Michal Bar-Natan, John Mascarenhas, Douglas Tremblay
Journal: Blood
Blood (2022) 140 (Supplement 1): 139–140.
https://doi.org/10.1182/blood-2022-167828
Published: 2022
Journal Articles

Molecularly Targeted Combination Therapy for Advanced Phase Myeloproliferative Neoplasm: MPN-RC 119

Michal Bar-Natan, John Mascarenhas, Aaron T. Gerds, Ruben Mesa, Vikas Gupta, Marina Kremyanskaya, Mikaela Dougherty, Frank Fabris, Kathryn Johnson, Ashley Yu, Heidi E. Kosiorek, Carolyn Mead-Harvey, Amylou C. Dueck, Ronald Hoffman, Raajit K Rampal
Journal: Blood
Blood (2022) 140 (Supplement 1): 3988–3990.
https://doi.org/10.1182/blood-2022-164678
Published: 2022
Journal Articles

Central Nervous System Specific Characteristics and Outcomes in Acute Myeloid Leukemia Patients with Neurologic Involvement

Dahniel Sastow, Yosef J.R.A Riazat-Kesh, Kyle Farina, Jonathan Feld, Michal Bar-Natan, Alla Keyzner, Lewis R. Silverman, Marina Kremyanskaya, John Mascarenhas, Douglas Tremblay
Journal: Blood
Blood (2022) 140 (Supplement 1): 11618–11620.
https://doi.org/10.1182/blood-2022-157300
Published: 2022
Journal Articles

Multimodal single-cell analysis of cutaneous T-cell lymphoma reveals distinct subclonal tissue-dependent signatures

Alberto Herrera, Anthony Cheng, Eleni P. Mimitou, Angelina Seffens, Dean George, Michal Bar-Natan, Adriana Heguy, Kelly V. Ruggles, Jose U. Scher, Kenneth Hymes, Jo-Ann Latkowski, Niels Ødum, Marshall E. Kadin, Zhengqing Ouyang, Larisa J. Geskin, Peter Smibert, Terkild B. Buus, Sergei B. Koralov
Journal: Blood
Blood (2021) 138 (16): 1456–1464.
https://doi.org/10.1182/blood.2020009346
Published: 2021
Includes: Supplemental data
Journal Articles

Results of a Phase II Study of PD-1 Inhibition in Advanced Myeloproliferative Neoplasms

Gabriela S. Hobbs, MD, Cansu Cimen Bozkus, Martha Wadleigh, MD, Lonette Sandy, Mikaela Doughtery, Kathryn Johnson, Gillian Sanchez, Julia E. Foster, NP, Molly Macrae, Tina T. Som, RN, Michal Bar-Natan, MD, Richard M. Stone, MD, Erin Moshier, MS, Camelia Iancu-Rubin, PhD, John Mascarenhas, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 14–15.
https://doi.org/10.1182/blood-2020-137294
Published: 2020
Journal Articles

Prognostic Significance of Hospitalization Status at Second Cycle of Hypomethylating Agent Induction Therapy in Acute Myeloid Leukemia Patients Ineligible for Intensive Chemotherapy

Douglas Tremblay, MD, Rafael Madero-Marroquin, MD, Guido Lancman, MD, Alexander Coltoff, MD, Jonathan Feld, MD, Jessica Caro, MD, Nicole Zubizarreta, MPH, Marina Kremyanskaya, Alla Keyzner, MD, Michal Bar-Natan, MD, Shyamala C. Navada, MD, Lewis R. Silverman, Janice L. Gabrilove, MD, John Mascarenhas, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5102.
https://doi.org/10.1182/blood-2019-123288
Published: 2019
Journal Articles

Significance of Abnormalities of PPM1D in Myeloproliferative Neoplasms

Bridget Marcellino, MD PhD, Joseph Tripodi, Michal Bar-Natan, MD, Harry Fruchtman, Noushin Farnoud, PhD, Min Lu, PhD, Heidi E. Kosiorek, MS, Amylou C. Dueck, PhD, Raajit K. Rampal, MD PhD, John Mascarenhas, MD, Vesna Najfeld, PhD, Ronald Hoffman, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4207.
https://doi.org/10.1182/blood-2019-129565
Published: 2019
Journal Articles

Gene expression–based discovery of atovaquone as a STAT3 inhibitor and anticancer agent

Michael Xiang, Haesook Kim, Vincent T. Ho, Sarah R. Walker, Michal Bar-Natan, Melodi Anahtar, Suhu Liu, Patricia A. Toniolo, Yasmin Kroll, Nichole Jones, Zachary T. Giaccone, Lisa N. Heppler, Darwin Q. Ye, Jason J. Marineau, Daniel Shaw, James E. Bradner, Traci Blonquist, Donna Neuberg, Claudio Hetz, Richard M. Stone, Robert J. Soiffer, David A. Frank
Journal: Blood
Blood (2016) 128 (14): 1845–1853.
https://doi.org/10.1182/blood-2015-07-660506
Published: 2016
Includes: Supplemental data
Journal Articles

MUC-1 Regulates MiR34a Expression in Acute Myeloid Leukemia Cells Resulting in an Accumulation of Granulocytic Myeloid-Derived Suppressor Cells

Athalia Rachel Pyzer, MD, Dina Stroopinsky, PhD, Hasan Rajabi, PhD, Jacalyn Rosenblatt, MD, Maxwell Douglas Coll, Salvia Jain, MD, Kristen Anna Palmer, Ashujit Tagde, PhD BPharm, Katarina Luptakova, MD, Malgorzata McMasters, MD, James D. Levine, MD, Robin Joyce, MD, Jon E. Arnason, MD, Myrna Rita Nahas, MD, Rebecca Karp Leaf, MD, Abigail Washington, Michal Bar-Natan, MD, Poorvi Somaiya Dutt, Donald Küfe, MD, David Avigan, MD
Journal: Blood
Blood (2015) 126 (23): 643.
https://doi.org/10.1182/blood.V126.23.643.643
Published: 2015
Journal Articles

MUC1 Inhibition Overcomes Chemotherapy Resistance in Acute Myeloid Leukemia

Myrna Rita Nahas, MD, Dina Stroopinsky, PhD, Hasan Rajabi, PhD, Ashujit Tagde, PhD, Athalia Rachel Pyzer, MD, Salvia Jain, MD, Maxwell Douglas Coll, Michal Bar-Natan, MD, Rebecca Karp, MD, Katarina Luptakova, MD, Kristen Anna Palmer, Poorvi Somaiya, Jon Arnason, MD, Malgorzata McMasters, MD, Robin Joyce, MD, James D. Levine, MD, Donald Kufe, MD, David Avigan, MD, Jacalyn Rosenblatt
Journal: Blood
Blood (2015) 126 (23): 2473.
https://doi.org/10.1182/blood.V126.23.2473.2473
Published: 2015
Journal Articles

Immunomodulatory Effect of MUC1-C in Acute Myeloid Leukemia

Dina Stroopinsky, PhD, Hasan Rajabi, PhD, Maxwell Douglas Coll, Athalia Rachel Pyzer, MD, Jacalyn Rosenblatt, MD, Salvia Jain, MD, Katarina Luptakova, MD, Malgorzata McMasters, MD, James D. Levine, MD, Robin Joyce, MD, Jon E. Arnason, MD, Rebecca Karp Leaf, MD, Myrna Rita Nahas, MD, Kristen Anna Palmer, Michal Bar-Natan, MD, Ashujit Tagde, PhD BPharm, Abigail Washington, Poorvi Somaiya, Donald Kufe, MD, David Avigan, MD
Journal: Blood
Blood (2015) 126 (23): 3659.
https://doi.org/10.1182/blood.V126.23.3659.3659
Published: 2015
Journal Articles

Mucin 1 is a potential therapeutic target in cutaneous T-cell lymphoma

Salvia Jain, Dina Stroopinsky, Li Yin, Jacalyn Rosenblatt, Maroof Alam, Parul Bhargava, Rachael A. Clark, Thomas S. Kupper, Kristen Palmer, Maxwell D. Coll, Hasan Rajabi, Athalia Pyzer, Michal Bar-Natan, Katarina Luptakova, Jon Arnason, Robin Joyce, Donald Kufe, David Avigan
Journal: Blood
Blood (2015) 126 (3): 354–362.
https://doi.org/10.1182/blood-2015-02-628149
Published: 2015
Includes: Supplemental data